You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Data sources consulted to complete the reporting template and scope of the reporting systems

From: Drug shortages in European countries: a trade-off between market attractiveness and cost containment?

Country National shortage reporting system Reporter Drugs included in reporting system National drug formulary for hospitals or community pharmacy consulted to complete reporting template
Belgium Federal Agency for Medicines and Health Products (FAGG) Marketing authorization holders Drug for which unavailability cause a risk for public health and have no therapeutic alternative Belgian Centre for Pharmacotherapeutic Information (BCFI)
Farmaco-contingentering.be Pharmacists Products subjected to supply quota  
The Netherlands Farmanco.nl Marketing authorization holders, wholesalers, pharmacists Unlimited Geneesmiddelenrepertorium.nl
England Pharmaceutical Services Negotiation Committee (PSNC) Pharmacists Products for community pharmacy only Eudrapharm
Italy Italian Medicines Agency (AIFA) Marketing authorization holders, health care providers, health departments, patients or associations Unlimited Italian Drug Formulary (AIFA)
Eudrapharm
Germany Federal Institute for Drugs and Medical Devices (Bfarm) Marketing authorization holders Products for treatment of threatening or serious diseases for which no alternatives are available Federal Institute for Drugs and Medical Devices (Bfarm)
Eudrapharm
Spain Spanish Agency for Medicines and Health Products (aemps) Marketing authorization holders or health authorities of autonomous communities Unlimited Spanish Agency for Medicines and Health Products (aemps)
France National Agency for Safety of Drugs and Health Products (ansm) Pharmacists and hospitals Drug for which unavailability cause a risk for public health and have no therapeutic alternative National Agency for Safety of Drugs and Health Products (ansm)